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Regulation of Fc receptors for IgG on cultured rat mesangial cells.
Localization of immune complexes (IC) to the mesangium may contnb-
ute to glomerular disease. Recently, we and others characterized Fe
receptors (FcyR) for IgG-IC on mesangial cells (MC). This study
examines regulation of FcyR by cAMP, interferon y (IFN-y) and by
macrophage colony stimulating factor (CSF-I), an agent controlling
Fc7R in leukocytes and generated by MC. Preincubation of MC (3rd to
6th subculture) with CSF-l, db-cAMP or IFN-y for two to 48 hours
resulted in a time dependent (maximal 24 to 48 hrs) two- to threefold
increase of specific [12511 IgG-IC binding to MC at 4°C. The increase of
Fe receptors induced by CSF-l, db-cAMP or IFN-y was confirmed by
enhanced binding of the monoclonal anti-Fe receptor antibody 2.4G2 to
MC. Uptake of IgG-IC at 37°C was also enhanced in MC pretreated
with CSF-1, db-cAMP or IFN-y. This indicates that the increase in
binding for IgG-IC is associated with functional receptors. Immunopre-
cipitation of extracts of [1251] surface labeled MC with polyclonal
anti-FcyR-Ab followed by SDS-PAGE also showed increased amounts
of [12511 FcyR protein after pretreatment with CSF-l, db-cAMP or
IFN-y. The pretreatment also enhanced staining of MC with anti-
Fe7R-Ab by immunogold-silver enhancement technique. We conclude
that MC express FcyR for IgG-IC that can be regulated by CSF-l,
cAMP and IFN-y, factors that may be important in glomerular immune
injury.
The renal glomerular mesangial cell (MC) represents a spe-
cialized pericyte which is considered to contribute to the
regulation of glomerular filtration and may play a role in
glomerular disease processes [1]. In a number of glomerular
immune diseases IgG immune complexes (IC) localize to the
mesangium, which may contribute to the inflammatory reaction
[2]. Based on these considerations we and others had previ-
ously examined macromolecular uptake by cultured rat mesan-
gial cells [3—8]. These studies demonstrated that cultured
mesangial cells take up serum-coated gold particles in a specific
manner involving coated-pits and coated vesicles [6]. Further-
more, binding of IgG-IC to MC is associated with the generation
of reactive oxygen species, PGE2 and platelet activating factor
[7, 8]. Our studies [8] and those of Sedor, Carey and Emanci-
pator [71 also indicated that these events depended on the Fe
portion of the IgG-IC, consistent with binding to Fe receptors
[7, 81. We have since further characterized an FeyR (Fe gamma
R) on cultured rat mesangial cells that is similar to the Fe
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gamma Rh present on murine macrophages [9]. This was
supported by the following evidence [9]:
1.) The Fe gamma Rh on rat MC binds aggregates of hgG2
and IgG1 in an Fe-dependent manner. This binding in turn is
blocked by monoelonal antibody 2.4G2 (MAb 2.4G2) which is
directed against an extracellular epitope of the murine Fe
gamma Rh [10].
2.) The FC gamma R is immunepreeipitated by MAb 2.4G2
and by a polyclonal Ab, both directed against murine Fe gamma
Rh, and eomigrates on SDS-PAGE with the Fe gamma Ru
present on murine macrophages [11, 12].
3.) Cultured rat MC stain uniformly with the polyclonal Ab
against murine Fe gamma Rh by indirect immunofluorescence.
4.) Furthermore, rat mesangial cells in culture express
messenger RNA that hybridizes on Northern blotting with a
specific eDNA probe for the murine Fe gamma Ru alpha [13].
Having established the presence of Fe gamma RI! on cultured
rat MC [91 it was of interest to examine factors regulating the
expression of this FcyRIh. Regulation of the FeyR in vitro has
been studied in some detail in the human and murine leukocyte
systems [14—17]. Sheth et al showed that stimulation of mono-
cytic cell line U937 by dibutyryl cyclic AMP (db-eAMP) re-
sulted in a dramatic increase in expression of the low affinity
Fe'yRII as monitored with monoelonal FeyR antibody 1V3 [14].
Monocyte-macrophage colony stimulating factor (CSF-1) and
immune interferon gamma (IFN-y) can also induce FeyRlI in
macrophage cell lines [15—17].
In the present study we therefore investigated the effects of
human recombinant CSF-1 (Hr-CSF-1), db-cAMP and rodent
recombinant interferon-gamma (IFN-y) on the expression of
FcyRII in cultured rat mesangial cells. We used: 1) binding and
uptake of hgG-IC and 2) binding studies with the monoclonal Ab
2.4 G2 directed against Fe gamma R; 3) immuneprecipitation
studies with a polyclonal antibody against the murine FeyRI!;
and 4) immunogold staining techniques for FcyR.
Methods
[125!] sodium (carrier free in NaOH) was obtained from
Amersham, Arlington Heights, Illinois, USA. Enzymobeads
were purchased from Biorad, Richmond, California, USA.
Immunoglobulin-free bovine serum albumin was from Sigma
Chemical Company, St. Louis, Missouri, USA. RPM! 1640
medium containing L-glutamine, penicillin (0.66 mglml)-strep-
tomycin (60 mg/mI) solution, fetal calf serum and Dulbecco's
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phosphate buffered saline were purchased from Flow Labora-
tories, Inc., McLean, Virginia, USA.
Rat IgG and Agarose anti-rat IgG were obtained from Sigma
Chemical Company. Goat anti-rat F(ab')2 was from Organon
Teknika Corporation, West Chester, Pennsylvania, USA. Au-
roprobe EM was from Janssen Biotech N.V., Olen, Belgium.
Pansorbin cells were obtained from Calbiochem, La Jolla,
California, USA. Sulfo-SHPP was from Pierce Chemical Com-
pany, Rockford, Illinois, USA.
Monoclonal antibody 2.4G2 and rabbit polyclonal anti-FcR
antibody were gifts from Dr. Jay Unkeless, Mount Sinai School
of Medicine, New York, New York, USA. Rodent recombinant
IFN-y was from Amgen Corp. and human recombinant CSF-l
was from Cetus Corporation.
Macrophage cell line J774 [101 was maintained in DMEM
with 5% FCS and 1% Pen-Strep.
Glomerular isolation and culture of mesangial cells
Male Sprague-Dawley rats (Charles River Breeders, Wilm-
ington, Massachusetts, USA) were maintained on tap water and
Purina rat chow ad libitum. Kidneys were removed under
pentobarbital anesthesia. The glomeruli were isolated and cul-
tured as previously described [9]. The culture medium con-
sisted of RPMI 1640 with glutamine supplemented with 10%
fetal calf serum, penicillin and streptomycin. After mesangial
cells had reached confluence (20 days after glomerular seeding)
they were subcultured according to previously published meth-
ods [8]. Mesangial cells were used after three to six subcultures.
The mesangial cells represent an apparently uniform cell pop-
ulation as evaluated by the following criteria: (a) morphology,
(b) uniform fluorescence with FITC-phallacidin for F-actin, (c)
uniformly positive immunofluorescence with the monoclonal
antibody Thy 1.1, (d) pattern of binding for the specific lectins
ConA, WGA, and RCA-I, (e) absence of immunofluorescence
with factor VIII antibody, antibodies for Ia or common rat
leukocyte antigen [8, 181.
Labeling of immuno globulins
Rat IgG and F(ab')2 fragments of monoclonal antibody 2.4G2
were dialyzed for 24 hours at 4°C against two changes of 2000
volumes of phosphate buffered saline pH 7.4. [1251] IgG and
[1251] F(ab')2 were prepared using enzymobeads, and immobi-
lized preparation of lactoperoxidase and glucose oxidase (Bio-
rad). To 50 d of enzymobeads were added sequentially: 25 d
PBS, 25 pg of IgG subclass, I mCi of Na [12511 (carrier free) and
25 1td of 1% Beta-D-glucose. The [125!] labeled proteins were
separated from free [125J] by desalting chromatography over a
sephadex G-25 column. Protein bound [1251] was determined to
be 90 to 95% by trichioroacetic acid precipitation. Final specific
activities of the [125f] IgG and F(ab')2 ranged from 1 to 3 x 106
CPM/g protein. lodinated proteins were stored at —20°C.
Preparation of rat F(ab')2 IgG fragments
F(ab')2 fragments from monoclonal antibody 2.4G2 were
prepared by the methods described by Rousseaux, Rousseaux—
Prevost and Bazin [19, 20]. IgG was adjusted to a concentration
of 10 mg/ml in PBS and dialyzed at 4°C against 0.1 M sodium
formate buffer pH 2.8 (three changes of 1000 volumes of buffer
for one volume of IgG solution) then against 0.1 M sodium
acetate buffer pH 4.5. Digestion with crystalline pepsin (Sigma
Chem. Corp.) was then performed for four hours at 37°C
(pepsin: IgG ratio, 1% wt/wt). The digest was run on a FPLC
superose 12 column and absorption was monitored at 280 nm.
Three peaks were observed. The peaks were run on SDS-
PAGE. For electrophoretic analysis 10 to 20 tg protein of each
peak were mixed with an equal volume of sample application
buffer containing 120 m'vi Tris-HC1 (pH 6.8), 4% SDS (wt/vol),
20% glycerol (vollvol), and heated for three minutes in a boiling
water bath. The samples were then run on 7.5% acrylamide gels
[21] at constant current and temperature (35 mA and 9°C,
respectively). Prestained high and low molecular weight stan-
dards (Biorad) served as markers. The second peak from the
FPLC was determined to be F(ab')2 by its migration at 100 kD.
Affinity purifi cation of MAb 2.4G2
An agarose anti-rat IgG affinity column was equilibrated with
PBS pH 7.4. Supernatant medium from rat hybridoma contain-
ing mAb 2.4G2 [10] was diluted 1:2 in PBS pH 7.4. This was
passed twice over the agarose anti-rat !gG affinity column. The
column was then washed with five bed volumes of PBS pH 7.4
and eluted with a glycine-HC1 buffer pH 3.5. Protein elution was
monitored by U.V. spectrophotometry at 290 nM. One single
protein peak was observed. This protein was determined to be
rat IgG by ELISA. The protein was dialyzed overnight in PBS
pH 7.4 at 4°C, spun at 2000 x g to remove insoluble aggregates,
and stored at —20°C.
Preparation of IgG immune complexes
Both radiolabeled and unlabeled immune complexes consist-
ing of rat IgG and F(ab')2 goat anti-rat IgG were prepared at
50% equivalence of antibody:antigen by the addition of F(ab')2
fragment of goat anti-rat IgG to a solution containing rat [125J]
IgG in PBS (pH 7.4) yielding soluble, intermediate size immune
complexes. The solution was incubated for eight hours on a
rocker at 4°C and then centrifuged at 2000 x g to remove
insoluble immune complexes and aggregates. The supernate
was recovered and used in binding experiments as rat IgG
immune complexes (IgG-IC) at the concentrations indicated in
Results.
Binding studies
For [1251] IgG-IC binding studies and [1251] 2.4G2 F(ab')2
binding studies, both radiolabeled and unlabeled proteins were
spun at 2000 x g to remove insoluble aggregates, and the
supernates were used for the experiments. Culture plates with
24 wells of confluent rat mesangial cells were washed free of
media and then pretreated for the times indicated with either
control media (1% fetal calf serum, 8% Nu 5), or control media
containing either Hr-CSF-1, db-cAMP, or rodent IFn-y at the
concentrations and times indicated in Results. Binding experi-
ments were performed after removing the respective media and
replacing them with Dulbecco's phosphate buffered saline (D-
PBS) combined with i mivi calcium, 100 mg/dl glucose, and 2
mg/ml bovine serum albumin (BSA). The cells were allowed to
equilibrate in this buffer for 30 minutes at 4°C. All subsequent
procedures were carried out at 4°C. For [1251] IgG-IC studies
the buffer was replaced with 1 ml of the same buffer containing
[12511 IgG-IC alone (0.5 g/ml) or with excess unlabeled IgG-IC
(100 g/ml) for determination for non-specific binding. After
incubation for two hours, each well was washed five times with
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2 ml of PBS with 2 mg/mi BSA. The cells in culture wells were
then dissolved by a 12 hour incubation with 0.5 ml in NaOH,
and subsequently collected with an additional 0.5 ml wash of
PBS with 2 mg/mi BSA. Radioactivity was determined in a
gamma counter.
Binding experiments with [125J] 2.4G2 F(ab')2 were carried
out in similar fashion except that 0.2 g/ml [125!] 2.4G2 F(ab')2
was used. Nonspecific binding was determined in the presence
of ascites containing 10 ig/ml of 2.4G2.
Uptake of IgG-IC by mesangial cells
For [12511 IgG-IC uptake studies, confluent cultured rat
mesangial cells in 24 well plates were pretreated with either
control media (8% Nu S, 1% FCS), or media containing db
cAMP (1 mM), (2SF-i (2000 U/mI), or !FN-y (100 U/ml) for 48
hours. The media were replaced with PBS containing 200 mg/dl
glucose and 2 mg/ml BSA which was allowed to equilibrate for
30 minutes at 37°C. The buffer was then replaced with 1 ml of
the same buffer containing [12511 IgG-IC (0.5 tg/ml) alone or
with addition of sodium azide (0.1 mM). Incubations were then
carried out for one hour at 37°C. After incubation, the cells
were washed five times with cold PBS containing 2 mg/mi BSA
and then dissolved with 0.5 ml in NaOH for determination of
radioactivity.
In some experiments the number of cells per well was
determined by removing the cells from the culture dish with
trypsin EDTA and counting them in a hemocytometer.
Cell surface iodination and immune precipitation
Mesangial cells in 75 cm2 flasks were pretreated for 24 hours
with either control media consisting of 1% FCS and 8% Nu
Serum, or control media with addition of db-cAMP (1 mM),
Hr-CSF-l (2000 U/mi) or IFN-y (100 U/mI). Equal numbers of
mesangial or J774 cells were used in each immune precipitation
experiment. J774 cells and rat mesangial cells were washed two
times with PBS in their culture flasks and iodination was by
addition of 10 ml of PBS containing 0.2 g sulfo-SHPP (Pierce
Chemical Company), 0.5 mCI Na [12511, 10 g Chloramine-T
and 24 ig sodium metabisulfite. The cells were incubated on ice
for 30 minutes and then washed five times with 15 ml of PBS
with 5 mri KI. The cells from the culture flasks were harvested
with a rubber policeman and spun at 3000 RPM for 10 minutes.
The pellets were resuspended in 0.1 ml of a modified RIPA
buffer consisting of 20 m Tris, 110 mivi NaCl, 10 mrvi EDTA, 2
mM Diisopropylfluorophosphate, aprotinin (100 K U/mi) and
1% NP-40 and incubated at 4°C for one hour to solubilize
surface proteins. The suspensions were then spun down at
11,000 x g and the supernates recovered.
Immune precipitation was performed in the following man-
ner: The supernates containing the solubilized iodinated pro-
teins were first precleared by incubating individual cell lysates
(0.1 ml each) with 25 d pansorbin for one hour at 4°C on a
rocker. The pansorbin was then spun down at 11,000 x g for 10
minutes and the supernates recovered for the immuneprecipi-
tation with 0.5 tg of polyclonal anti-FcyR antibody (rabbit) for
12 hours at 4°C. Following this, 25 d of pansorbin were added
and incubations continued at 4°C on a rocker for 90 minutes.
The precipitates were obtained by centrifugation of 11,000 X g
for 15 minutes. The pellets were washed five times by recen-
trifugation in PBS containing 5 mrvi KI. To the pellet, 20 pi of
Laemmli sample buffer [21] containing 1 mrvi DTT was added
and boiled for three minutes. After centrifugation at 11,000 x g
for 15 minutes to remove insoluble material, the supernates
were subjected to SDS-PAGE (8%) as described by Laemmii
[21] and detailed above. The gel was dried followed by autora-
diography.
Immunogold staining of MC for Fc gamma R
Cultured rat mesangial cells were grown for five days on
plastic slides (Lab-Tek Chamber Slides) and subsequently
cultured in media only or media containing db-cAMP (1 mM),
CSF-i (2000 U/mi) or IFN-y (100 U/mi). The cells were washed
with PBS after a 48 hour incubation with the experimental
agents, and fixed in paraformaldehyde (3.5%) for five minutes
followed by washing with PBS. This was followed by incuba-
tion with 10 sg/ml polyclonal rabbit anti-FcyR antibody for 30
minutes at room temperature and extensive washing with PBS.
After 40 minutes incubation with anti-rabbit IgG coated gold
particles (10 nm Janssen Pharmaceuticals), the cells were again
washed followed by an 18 minute incubation with Silver Intense
kit (Janssen) for enhancement of the gold particles. The slides
were again washed followed by visualization and photography
with a Zeiss microscope. Controls included rabbit preimmune
serum or omisson of the first antibody.
[3H] thymidine proliferation assay
Cells were plated in 96 well plates at 20,000 ceils/ml and
grown in RPM! with 10% FCS for four days. Media were
removed and replaced with media consisting of 1% FCS, 8% Nu
Serum containing 1 Ci/ml [3H] thymidine and the experimental
agents: db-cAMP, !FN-y or Hr-CSF-1 as indicated in the
Results. [3H] thymidine incorporation into DNA was deter-
mined after 24 hours of culture using a Mash harvester and
scintillation counting. All experiments were carried out in
triplicate or quadruplicate and means of these served as a single
experiment.
Statistical evaluation was by paired or unpaired Students
t-test as appropriate.
Results
Binding of IgG-IC
Previously we have shown that IgG-IC and aggregates of rat
IgG2 bind to cultured rat mesangial cells by an Fc dependent
mechanism [8, 9]. For the present experiments we used IgG-IC
consisting of rat IgG and F(ab')2 fragments of goat anti-rat IgG.
In preliminary experiments the time course of IgG-IC binding to
mesangial cells was determined. Equilibrium binding occurred
after two hours at 4°C. Preincubation of rat MC with db-cAMP
(1 mM) IFN-y (100 U/mi) or Hr-CSF-i (2000 U/ml) resulted in a
time dependent enhancement of IgG-IC binding as compared to
controls (Fig. 1). Two- to threefold increases of binding oc-
curred at 12 to 24 hours for Hr-CSF-1 or db-cAMP pretreat-
ment, while enhancement of binding with IFN-y pretreated
cells required 48 hours. Specificity of binding was established in
each case by greater than 75% displacement of [1251] IgG-IC
binding in the presence of excess (100 g/ml) of unlabeled
IgG-!C. Figure 2 shows the summary of results after 48 hours of
pretreatment.
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Fig. 1. Binding of['251J IgG-IC to cultured rat MC. MC were grown to
confluency in 24-well culture plates and then pretreated for the times
indicated under either control conditions (0) or with addition of
db-cAMP (U, 1 mM), CSF-1 (, 2,000 U/mI) or IFN-y (•, 100 U/mI).
Binding of [1251] IgG-IC was determined at 4°C and is expressed as ng
of IC bound per 100 jg of mesangial cell protein. Results shown are
means SEM of four series of experiments.
To assess the possibility that an increase in FcyR number
might have been due to endotoxin contamination of the exper-
imental agents, binding of IgG-IC was carried out on mesangial
cells pretreated for 48 hours with E. coil lipopolysaccharide at
concentrations from 0.01 to 100 ng/ml. No difference in binding
of IgG-IC occurred after pretreatment with any of the concen-
trations of lipopolysaccharide (results not shown). Thus the
enhancement of FcyR binding activity after CSF-l, IFN-y or
db-cAMP cannot be explained by potential endotoxin contam-
ination.
Binding of monoclonal 2.4G2 antibody
To further quantify the number of FcyR on MC, we per-
formed a series of binding experiments with [12511 labeled
F(ab')2 fragments of the monoclonal antibody 2.4G2. Previ-
ously we have shown that MAb 2.4G2 immunoprecipitates a
protein from rat MC that comigrates on SDS-PAGE with the Fc
receptor present on murine J774 macrophages and that MAb
2.4G2 inhibits binding of IgG aggregates to rat mesangial cells
[91. MAb 2.4G2 binds to the extracellular part of FcyR by its
antigen recognition site, allowing determination of FcyR sites
by labeled F(ab')2 fragments of 2.4G2. As shown in Figure 3,
binding of F(ab')2 fragments of 2.4G2 was also increased
twofold by CSF-1 or IFN-y and threefold by db-cAMP treat-
Control CSF-1 db-cAMP lFN-y
2000 U/mi 1 mM 100 U/mI
Fig. 2. Binding of['251J IgG-IC to MC after 48 hour pretreatment under
control conditions or with addition of CSF-1, db-cAMP or IFN-y (see
legend Fig. 1 for details). Results are means SEM of 16 experiments
under control conditions, 10 with db-cAMP, 11 with CSF-1 and 16 with
IFN-y. Asterisks indicate P < 0.05 or better as compared to control.
ment of cells. Thus the results of the binding experiments with
2.4G2 confirm that db-cAMP, IFN-y and CSF-1 can each
increase the number of surface Fey receptors on cultured rat
mesangial cells.
Uptake of IgG-IC
Uptake studies for IgG-IC were performed in order to exam-
ine whether the increase in IgG-IC and 2.4G2 binding at 4°C was
also translated into increased phagocytosis of IgG-IC by MC.
MC were pretreated for 48 hours under control conditions (8%
Nu serum, 1% FCS) or with CSF-l (2,000 U/mI), db-cAMP (1
mM), or IFN-y (100 U/ml). Uptake of [125J] IgG-IC (0.5 g/ml)
was performed for one hour at 37°C under control conditions, or
in the presence of sodium azide (0.1 mM) to reduce cellular ATP
content and thus active uptake mechanisms. As shown in
Figure 4 pretreatment with IFN-y, CSF-l or db-cAMP resulted
in two- to fivefold increase in uptake of IgG-IC as compared to
control. Sodium azide reduced uptake by 30 to 50% under all
conditions, consistent with an active uptake process. Interest-
ingly, the amounts of IgG-IC associated with MC in the
presence of sodium azide (at 37°C) are closely comparable to
the binding data (4°C), indicating that the number of Fc gamma
Ron MC is increased by CSF-l, db-cAMP and IFN-y, and that
those receptors actively contribute to phagocytosis of IgG-IC.
Immunoprecipitation of the Fc gamma R
To demonstrate an increase in the amount of FcyR present on
cells pretreated with the experimental agents, immuneprecipi-
tation experiments were performed with a polyclonal anti-FcyR
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Control CSF-1 db-cAMP 1FN-y
2000 U/mi 1 mrvi 100 U/mi
Fig. 3. Binding of [125jj F(ab')2 fragment of monoclonal antibody 2.4
G2 to rat MC. Pretreatment with experimental agents was for 48 hours
and binding of IC was determined as ng IC bound per 100 g mesangial
cell protein. Results are means SEM from 6 experiments each for
CSF-l and db-cAMP and from 3 for IFN-y. Asterisks indicate P < 0.05
or better as compared to control.
antibody. We have previously shown that this antibody precip-
itates a 45 to 5OkD protein band from rat mesangial cells that
comigrates with the Fc Ru protein present on J774 macro-
phages. Equal numbers of rat mesangial cells on J774 were used
in each immunoprecipitation experiment. Rat mesangial cells
were pretreated in control media (8% Nu Serum, 1% FCS) or
media containing db-cAMP, CSF-l or IFN-y for 24 hours. The
cells were then surface labeled with [12511 followed by a
preclearing step and immunoprecipitation with the polyclonal
anti-FcyR antibody. Immune precipitates from J774 Mø
showed the typical broad 45 to 55 kD labeled protein band for
the murine Fc Ru on autoradiogram [11, 121. Control rat
mesangial cells showed a similar broad band which comigrated
with that from J774 MØ. As shown in Figure 5, the autoradio-
graphic intensity of this immunoprecipitated protein band was
increased after pretreatment with db-cAMP, CSF-l and IFN-y.
These results were confirmed in another separate set of exper-
iments. These findings confirm the results of the binding studies
and indicate that db-cAMP, CSF-l and IFN gamma enhance the
amount of the FcyR on the surface of rat MC.
Immunogold staining for FcyR
We performed immunostaining to determine whether all
pretreated cells showed an increase in the number of FcyR.
Immunostaining was performed on mesangial cells with the
polyclonal anti-FcyR antibody followed by a second incubation
with 10 n gold coated anti-rabbit IgG and silver enhancement.
As shown in Figure 6, when compared to control, db-cAMP and
=
CSF-1 db-cAMP iFN-y
2000 U/mI 1 mr,i 100 U/mI
Fig. 4. Uptake of IgG-IC by MC pretreated for 48 hours with experi-
mental agents (see legend Fig. 1). Uptake was determined after 1 hour
of incubation at 37°C in control buffer () or buffer containing sodium
azide (VA, 0.1 mM). Results are means SEM of 4 series of experiments.
Asterisks indicate P < 0.05 or better as compared to the respective
controls.
CSF-l treated cells showed a uniform increase in surface
staining with the polyclonal anti-FcyR antibody, as evidenced
by the increase in silver grains overlying the cells. A similar,
though less pronounced enhancement occurred with IFN-y.
Use of preimmune rabbit serum or omission of the first antibody
resulted in negligible background immunostaining (not shown).
Proliferation studies
Experiments with incorporation of [3H] thymidine into DNA
were performed to exclude the possibility that the increase in
FcyR could have resulted from an effect of db-cAMP or CSF-l
on MC proliferation. Mesangial cells were therefore grown
under the same conditions, (8% Nu Serum, 1% FCS) on 96 well
plates for 48 hours with increasing concentration of db-cAMP
or CSF-l in the presence of [3H] thymidine. As shown in Figure
7, [HI thymidine incorporation into DNA of rat MC was
unchanged in the presence of increasing concentrations of
Hr-CSF-l. Preincubation with db-cAMP resulted in a dose-
dependent inhibition of [3H] thymidine incorporation when
compared to control media (Fig. 7). IFN-y caused a 20%
decrease in [3H1 thymidine incorporation in rat MC, compara-
ble to results obtained by us in mouse MC [221. Thus, the
increase in IgG-IC binding sites and in immuneprecipitable
Fc7R cannot be accounted for by effects of CSF-1 or db-cAMP
on cell number.
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Fig. 5. Autoradiogram of SDS-PAGE of immune precipitated FcyR
from J-774 cells and rat mesangial cells. MC were pretreated for 48
hours under control conditions or with addition of db-cAMP (1 mM),
CSF-l (2000 U/mI) orIFN.y(100 U/ml). Cells were surface labeled with
[1251] and were immuneprecipitated as described in the Methods section
with the polyclonal rabbit anti-FcyR antibody. The precipitates were
run on a 7.5% SDS-PAGE followed by autoradiography. The results
shown are representative of 2 comparable experiments.
Discussion
Our present results expand on the presence of FcyR on
cultured rat MC and show that these receptors can be up-
regulated by treatment with db-cAMP, CSF-1 and IFN-y. This
is demonstrated by increased binding of IgG-IC and of the
monoclonal anti-FcyR antibody 2.4 G2, by enhanced uptake of
IgG-IC, by an increase in immunoprecipitable, surface-labeled
FcyR, and finally by enhanced immunogold staining for FcyRII.
Previous studies from a number of laboratories, including our
own, had shown that cultured MC are capable of phagocytosis
[1, 3—81. This occurs in a manner involving coated-pits and
vesicles and is associated with generation and release of PGE2,
12-lipoxygenase products, reactive oxygen species and platelet
activating factor [3—8]. The generation of PGE2, reactive oxy-
gen species and platelet activating factor is dependent on the Fc
part of IgG consistent with Fc7R mediation. Recently we
characterized an Fc7R on rat MC that by IgG subclass binding
by immunoprecipitation with antibodies against FcyR and by
Northern blot analysis would correspond to the murine FcyRlI
alpha type [9]. Thus cultured MC are capable of Fe-dependent
phagocytosis and release of mediators of inflammation; yet the
cultured MC are not macrophages but represent a specialized
vascular pencyte. This has been documented by a number of
criteria, including morphology, presence of actin stress fibers,
contractility in response to vasoactive agents, generation of
matrix components, proliferation through multiple passages of
cell culture, absence of surface markers for leukocytes and a
Fig. 6. Phase contrast and immunogold-silver enhancement micros-
copy pictures of MC pretreared under control conditions or with
experimental agents for 48 hours. Pretreatment was as described in
Figs. 1—5. After fixation MC were incubated with the rabbit anti-Fc7R
serum followed by anti.rabbit IgG coated gold particles and silver
enhancement staining. The granularity overlying the cells represents
binding of the antibody to the FcyR. Only background silver staining
was seen when preimmune serum was used (not shown).
specific pattern of eicosanoid synthesis that markedly differs
from macrophages [8, 9, 18].
Our binding studies with IgG-IC or the F(ab')2 fragments of
2.4G2 indicate that the number of FcyR on mesangial cells
doubles or triples after 48 hours of incubation with IFN-y. The
stimulation of FcyR on MC by IFN-y is similar to that reported
for macrophages U5]. Furthermore, IFN-y stimulates produc-
tion of CSF-1 in human macrophages and—as recently shown
by us—in mouse MC [22]. CSF-1 has been described as a
cytokine specific for proliferation, maturation and survival of
monocyte-macrophages [231. In macrophages CSF-l also en-
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Fig. 7. Effects of increasing concentrations of db-cAMP (0) or CSF-1
(U) on 13jjj thymidine incorporation into MC. For details refer to
Methods. Results are means SEM of 4 to 8 experiments and are shown
as percentages of the control incorporations.
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hances the number of FeyRII [24]. Recently we demonstrated
that cultured mouse MC not only produce CSF-1 but also
express receptors for CSF-l [22]. Our present observation that
in cultured rat MC CSF-1 increases the number of FcyR further
illustrates that the MC can be a target site for CSF-l, in addition
to producing CSF-l. Thus CSF-l could act in an autocrine
fashion in MC. In this context it is of special interest that IFN-y
can stimulate production of CSF-l by MC. This raises the
possibility that IFN-y increases CSF-l which in turn enhances
the number of FcyR. The fact that induction of FcyR in
response to IFN-y was delayed (48 hrs) in comparison to CSF-l
would be in agreement with such a possibility. At present this
remains a hypothesis that will require further studies.
Similar to observations in leukocytes, db-cAMP also in-
creased FcyR in MC [14]. It remains to be established which
physiological agents might stimulate FcyR expression via
cAMP in MC. Potential candidates would include PGE2 and
isoproterenol as both agents stimulate adenylate cyclase in
glomeruli and MC [1, 25].
The up-regulation of surface FcyR on MC by db cAMP,
CSF-l and IFN-y was not only shown by binding of IgG-IC, but
also by binding of F(ab')2 fragments of the monoclonal antibody
2.4G2, directed against murine FcyR [10, 26]. Our previous
studies had shown that mAb 2.4G2 not only bound to the FcyR
of rat MC, but also blocked receptor binding for IgG aggregates
[9]. An increase in the amount of FcyR on MC after the
experimental pretreatments was further substantiated by the
immunoprecipitation experiments from surface-labeled MC.
The immunoprecipitated material migrated as a predominant
band around 50 to 54 kD, with minor bands apparent from 45 kD
on. The heterogeneity of the FcyR on SDS-PAGE has been
ascribed to different degrees of glycosylation [12, 27]. Clearly
the immunoprecipitable material from MC comigrates with that
from the murine macrophage cell line J774, as previously
described [9]. The marked increase in surface-labeled immuno-
precipitate after pretreatment with db-cAMP, CSF- 1 or IFN-y
shows that the enhanced binding of IgG-IC and mAb 2.4G2 is in
fact associated with more surface FcyR protein.
Pretreatment with db-cAMP, CSF-l or IFN-y not only in-
creased the number of FcyR on MC, but these receptors were
also functional for phagocytosis, as demonstrated by the uptake
experiments performed at 37°C. The slight differences in the
degree of stimulation obtained with CSF-l and IFN-y in the
binding and uptake experiments are probably due to inter-
experimental variations. At present we can not exclude, how-
ever, that IFN-y may influence the number of FcyR more than
their function.
The increase in Fc7R (determined by IgG-IC binding) re-
quired at least 12 hours of pretreatment in the case of db-cAMP
or CSF-1 and 24 to 48 hours in the case of IFN-y. No changes
were observed after two hours of pretreatment. This makes
insertion of performed FcyR into the cell membrane an unlikely
explanation, but may rather indicate a requirement for de novo
protein synthesis. The exact mechanisms responsible for the
increase of FcyR number after pretreatment with db-cAMP,
CSF-1 and IFN-yrequire further experiments and may differ for
the various experimental agents. Clearly, however, they can
not be explained by effects on MC proliferation. IFN-y is
known to be antiproliferative [281 and decreased [3H1 thymidine
incorporation by 20%, as also previously noted by us in mouse
MC [22]. CSF- I had no effect on [3H] thymidine incorporation
into DNA of MC under the conditions studied. Db cAMP even
caused a marked and dose dependent inhibition of [3H] thymi-
dine incorporation as also reported by others [29].
The increase in FcyR with the experimental pretreatments
appeared to involve most MC as judged from immunohisto-
chemical data. These observations also argue against the pos-
sibility that a small subpopulation in our MC culture could be
responsible for the IgG-IC binding and uptake. The immu-
nogold method to demonstrate FcyR also confirms our previous
findings obtained with indirect immunofluorescence.
At present the role of the FcyR on MC and its regulation by
IFN-y, CSF-1 and cAMP remain speculative. We had previ-
ously proposed that under normal conditions the receptor may
perform housekeeping functions, such as removal of locally
deposited IgG-IC in the glomerulus. The up-regulation of FcyR
in MC by "inflammatory" cytokines such as IFN-y and CSF-1,
raises the possibility that these mediators may activate the
normally "quiescent" mesangial pericytes and transform them
into active participants in glomerular immune injury.
Reprint requests to Dr. Del/el Schlondorff, Albert Einstein College of
Medicine, 1300 Morris Park Avenue, Bronx, New York 19461, USA.
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